EBITDA margin recovery to 21-23% in Q4 FY26
Management expects EBITDA margin to improve to 21-23% in Q4, driven by higher PVC/CPVC prices and better demand.
EPIGRAL / guidance tracker
Keep management guidance in view.
Epigral · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
margins
Chlorotoluene plant to contribute meaningfully from FY27
The chlorotoluene plant, commissioned in March 2025, is expected to generate sizable revenue and profit from FY27 onwards as customer approvals and long-term contracts ramp up.
CPVC capacity doubling on track for commissioning by September 2026
The CPVC capacity expansion project is progressing on schedule and within budget, with commissioning expected around September 2026.
New chemistry capex plan to be announced in coming months
Management is finalizing a new chemistry capex plan and expects to announce details in the next couple of months, targeting growth from FY29 onwards.